医学
物理疗法
随机对照试验
生活质量(医疗保健)
可视模拟标度
腰痛
干预(咨询)
背痛
临床试验
慢性疼痛
替代医学
内科学
护理部
病理
作者
Qingtang Yang,Shiliang Yu,Jianbin Wang,Caiyun Zheng,Xiaofeng Liang,Debiao Yu,Xiangmei Chen
出处
期刊:Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2021-01-29
卷期号:100 (4): e24448-e24448
被引量:1
标识
DOI:10.1097/md.0000000000024448
摘要
Chronic low back pain (CLBP) is 1 of the common clinical diseases, and many treatment methods can only improve the symptoms of pain in the short term. Traditional Chinese sports - Baduanjin has been proven to have a positive effect on chronic low back pain. However, the quality of the research is low, the sample size is small, and safety observations are lacking. We describe the protocol of a randomized controlled trial to study the efficacy and safety of Baduanjin chronic low back pain.This randomized, controlled, evaluator-blind, two-arm, parallel clinical trial will include 90 outpatients with chronic low back pain recruited from the First Hospital of Nanping City, Fujian Province. The patients were randomly assigned to the intervention group (Baduanjin exercise training) and the control group (not receiving any special exercise training) at a ratio of 1:1. Patients in the intervention group will receive Baduanjin exercise training 3 times a week for 24 weeks. The 2 groups received a 4- week follow-up observation at 24 weeks. The main result from the intervention before intervention to 24 weeks later, and the follow-up of 4 changes the visual analog scale score at weeks, and by independent t are tested groups. It will also review the Pain-related disability index, The Quebec Back Pain Disability Scale, Health-related quality of life, Roland Morris (Roland Morris) Disability Questionnaire, Overall Perceived Effect (OPE) and safety Compare. Cost data for cost-benefit and cost-benefit analysis will be collected.This will be the first study to compare the effectiveness and safety of Baduanjin for patients with chronic low back pain. The results may help healthcare professionals make clinical decisions and may reduce the cost of treatment for this disease.ChiCTR2000033908.
科研通智能强力驱动
Strongly Powered by AbleSci AI